16 results about "Common cold" patented technology

This invention discloses a traditional Chinese medicine composition for improving fever in wind-heat common cold, belonging to the field of traditional Chinese medicine preparation technology. Addressing the shortcomings of existing Western medicines that suppress fever through central nervous system suppression, easily damaging organs and inhibiting microcirculation, and the limitations of traditional Chinese medicine preparations such as bitter and cold properties that astringe pathogens, causing low-grade fever rebound, damaging yin and spleen, and insufficient ability to resolve phlegm and strengthen the body, this invention innovatively combines the principles of monarch, minister, assistant, and guide herbs in a synergistic formulation based on the core microscopic pathogenesis of wind-heat common cold: "constriction of visceral microvessels, stagnation of heat pathogens, high fever depleting body fluids, fluid deficiency and blood stasis, and phlegm production due to stagnation." This invention is prepared using gardenia, platycodon, angelica, peppermint, ophiopogon, dandelion, lily, coix seed, and rehmannia as core raw materials. It utilizes pungent and dispersing herbs to open up the microcirculation of the body surface and lungs, dispersing stagnant heat and replacing the traditional bitter and cold heat-suppressing mechanism. Combined with heat-clearing and anti-inflammatory components, it targets and inhibits the release of inflammatory factors, resulting in stable fever reduction. Small doses of yin-nourishing herbs repair the damage to body fluids and blood caused by high fever, reversing the pathology of fluid deficiency and blood stasis. Spleen-strengthening and dampness-removing herbs harmonize the medicinal properties and strengthen the spleen. This invention achieves a balance of hot and cold properties, and addresses both tonification and purgation, providing a one-stop solution for complex symptoms such as fever, sore throat, nasal congestion, yellow phlegm, dry mouth, weakness, and fatigue caused by dampness in wind-heat colds. It provides stable fever reduction without rebound, and avoids the side effects of Western medicine and bitter and cold Chinese patent medicines. It addresses both the symptoms and the root cause, effectively avoiding post-cold sequelae and reducing the recurrence rate. Furthermore, the preparation process is simple, allowing for processing into various dosage forms, suitable for industrial mass production and widespread clinical application, possessing extremely high medical value and market potential.

The application discloses a traditional Chinese medicine composition for treating common cold by simultaneously resolving exterior and interior, and belongs to the technical field of traditional Chinese medicine compound. The application provides two groups of traditional Chinese medicine compositions which are used according to syndrome differentiation: the composition for treating wind-cold common cold is based on Xiaolingtang and Wuling San, and is combined with apricot kernel, purple yam, forsythia flower and the like; the composition for treating wind-heat common cold is based on Dalingtang, Wuling San and Houpu Dahuang Tang, and is combined with apricot kernel, radix trichosanthis and the like. According to the theory of cold damage of six meridians, the application divides the source of common cold into wind-cold and wind-heat, establishes the treatment method of simultaneously resolving exterior and interior, resolves exterior pathogen, regulates triple energizer and resolves internal pathogen, regulates the human body environment, and thus treats common cold. The application has the characteristics of simple and intuitive syndrome differentiation standard, reliable prescription combination, industrialized oral preparation, treatment of wind-cold common cold and wind-heat common cold, fast effect, wide indication and convenient use.

The present invention provides an aqueous solution composition capable of rapidly preventing, alleviating or eliminating symptoms of acute respiratory diseases by applying a hypertonic aqueous solution composition containing molecular iodine to all parts of the eyes, oral cavity, nasal cavity, and respiratory tract. The present invention provides a hypertonic aqueous solution composition containing molecular iodine, which can prevent and eliminate acute respiratory infectious diseases such as cold, flu, and COVID-19, and can rapidly alleviate or eliminate runny nose and nasal congestion caused by allergic and non-allergic rhinitis.

The present disclosure describes a method of treating a respiratory condition, wherein the respiratory condition is a respiratory enterovirus infection, an upper respiratory infection, a common cold, or a combination thereof, in a human subject with COPD which includes administering to the subject a therapeutically effective amount of vapendavir or a pharmaceutically acceptable salt thereof, thereby treating the respiratory condition in the subject. Pharmaceutical formulations of vapendavir and pharmaceutically acceptable salts thereof are also disclosed.

The invention belongs to the technical field of traditional Chinese medicines, and discloses a formula for preventing and treating new crown, influenza A and cold, which comprises the following components by weight: 12-17g of boat-fruited sterculia seed, 12-17g of grosvenor momordica fruit, 12-17g of dwarf lilyturf tuber, 8-12g of honeysuckle flower, 12-17g of wild chrysanthemum flower, 12-17g of sweet wormwood herb, 18-22g of mint and 12-17g of Chinese mosla herb. The formula disclosed by the invention is used for treating and preventing new crown influenza, influenza A, influenza, viral influenza and common cold, and is effective for pharyngeal pain, oral internal heat and gingival swelling.

This invention discloses a traditional Chinese medicine composition for treating acute and subacute cough after a cold and its application. The traditional Chinese medicine composition includes the following components: 10-15 parts of Perilla frutescens seed, 10-15 parts of Perilla frutescens stem, 10-15 parts of Paeonia lactiflora, 10-15 parts of processed Eriobotrya japonica leaf, 6-9 parts of Prunus armeniaca seed, 6-9 parts of Platycodon grandiflorus, 10-15 parts of Cinnamomum cassia twig, 10-15 parts of processed Pinellia ternata, 6-9 parts of Fritillaria cirrhosa, 15-30 parts of Poria cocos, 6-9 parts of Citrus reticulata peel, 6-9 parts of Citrus reticulata fibrosum, 9-15 parts of Scutellaria baicalensis, and 6-9 parts of processed Glycyrrhiza uralensis. The traditional Chinese medicine composition of this invention follows the core treatment principle of "promoting lung function and relieving cough, resolving phlegm and soothing the throat, and clearing away residual pathogens". Targeting the pathogenesis characteristics of acute and subacute cough after a cold, the principal and assistant herbs directly target the core symptoms of cough, quickly relieving acute manifestations such as cough and sore throat; the adjuvant herbs work on multiple targets, taking into account resolving phlegm, clearing heat, and unblocking the meridians, adapting to different syndrome types and disease stages, and preventing prolonged cough; the guiding herbs harmonize the properties of the herbs, mildly protect the body's vital energy, avoid the harshness of the medicine damaging body fluids, and at the same time eliminate the source of phlegm production.

Provided are a traditional Chinese medicine composition and a method for preparing same. The composition is prepared from the following raw materials and optionally a pharmaceutically acceptable excipient. The raw materials include: Astragali Radix, Lonicerae Flos, Saposhnikoviae Radix, Cinnamomi Ramulus, Paeoniae Alba Radix, Forsythiae Fructus, Atractylodis Macrocephalae Rhizoma, Platycodonis Radix, Zingiberis Rhizoma, Jujubae Fructus, Citri Reticulatae Pericarpium, Isatidis Radix, and Glycyrrhizae Radix et Rhizoma. The composition can be used for preparing a medicament for treating common cold, viral infection, fever, inflammation, or cough, for relieving phlegm, for relieving pain, for immunoregulation, or for protecting influenza A close contacts.

This invention discloses a pharmaceutical composition for treating pediatric colds with stagnation, its preparation method, and its uses. It is a preparation made from active ingredients and pharmaceutically acceptable excipients. The active ingredients are prepared from the following raw materials in the indicated weight ratios: Ephedra 4-7 parts, Bitter Almond 5-8 parts, Mulberry Bark 5-8 parts, Lycium Bark 7-10 parts, Peppermint 4-7 parts, Tangerine Peel 4-7 parts, Areca Peel 7-11 parts, Malt 10-14 parts, and Licorice 3-6 parts. The preparation is obtained by decoction with water, or by decoction with water to obtain an extract, followed by distillation to extract the volatile oil. The extract and volatile oil are then combined to obtain the final preparation. This pharmaceutical composition is widely used clinically to treat pediatric colds with stagnation, particularly pediatric colds with wind-cold and stagnation, with definite efficacy. It can also be used in the preparation of medicines for preventing and treating pediatric colds with stagnation.

To provide a compound of formula (I) as described herein, pharmaceutically acceptable salts, pharmaceutical compositions containing such compounds, and methods for using these compounds, salts, and compositions to treat viral infections. [Solution] The present invention relates to a novel 1,3-dioxoindene compound that is an inhibitor of picornaviruses, including coxsackievirus, enterovirus, echovirus, poliovirus, and rhinovirus, and is therefore useful for treating viral infections, including polio, paralysis, acute hemorrhagic conjunctivitis, viral meningitis, hand-foot-and-mouth disease, vesicular diseases, hepatitis A, myositis, myocarditis, pancreatitis, diabetes mellitus, epidemic myalgia, encephalitis, common cold, herpangina, foot-and-mouth disease, asthma, chronic obstructive pulmonary disease, pneumonia, sinusitis, or otitis media.

This invention discloses a traditional Chinese medicine composition for treating wind-heat type common cold and its preparation method, relating to the field of traditional Chinese medicine technology. The composition is made from the following raw materials in parts by weight: 15-20 parts of *Ilex asprella*, 10-15 parts of mulberry leaf, 4-10 parts of wild chrysanthemum, 4-10 parts of *Viola yedoensis*, 10-15 parts of *Senecio scandens*, and 4-10 parts of dandelion. The preparation method includes: mixing the raw materials, soaking in 6-10 times the amount of water for 15-60 minutes; decocting twice, maintaining the boil for 1.5-2 hours each time, filtering and combining the filtrates; concentrating to a relative density of 1.14-1.18 at 80°C, cooling, adding 95% ethanol to achieve an alcohol content of 65-70%, stirring and standing for 12-24 hours, collecting the supernatant; recovering the ethanol under reduced pressure to obtain an extract and concentrating to a relative density of 1.25-1.30 at 80°C. This invention solves the problems of existing drugs for treating wind-heat colds having a narrow range of indications, insufficient extraction of effective components or incomplete removal of impurities in the preparation process, and the need to improve product quality stability.

Compositions and methods of treating a coronavirus infection in a subject are provided. The methods generally include administering to the subject an effective amount of a probenecid, metabolite or analog thereof, or a pharmaceutically acceptable salt thereof. The methods can be therapeutic and / or prophylactic. The amount of probenecid, metabolite or analog thereof, or a pharmaceutically acceptable salt thereof can be effective, for example, to reduce viral replication, reduce one or more symptoms of a disease, disorder, or illness associated with the virus, or a combination thereof. In preferred embodiments, the virus is a severe acute respiratory syndrome-associated coronavirus, such as SARS-CoV-2 or SARS-CoV, a Middle East respiratory syndrome-associated coronavirus, such as MERS-CoV, or a coronavirus that causes the common cold.

The application provides a method and a cold mask for rapidly treating cold by traditional Chinese medicine fumigation, and belongs to the fields of traditional Chinese medicine and traditional Chinese medicine materials. The fumigation traditional Chinese medicine composition for treating cold and an oxidizing agent are added into the mask, so that the effective substances of the traditional Chinese medicine composition and the oxidizing agent are gasified in the mask, and the gasification product is used for fumigating the respiratory tract; the drug is targeted to the site, and a very low dosage can kill bacteria, fungi, spores and viruses (including the novel coronavirus) in the respiratory tract, repair the respiratory tract mucosa lesion and improve the human body resistance, so that the cold is rapidly treated; and the single protection function of the existing mask is changed into a protection and treatment dual function.

The invention discloses a traditional Chinese medicine composition for treating new crown cold and cough. The traditional Chinese medicine composition is prepared from the following traditional Chinese medicinal materials: radix paeoniae alba, poria, fingered citron, radix curcumae, szechwan chinaberry fruit, herba artemisiae scopariae, pericarpium arecae, liquorice, fructus xanthii, fermented soybean, fructus forsythiae, radix scutellariae, radix saposhnikoviae, pericarpium trichosanthis, platycodon grandiflorum, radix stemonae, radix asteris, tussilago farfara, plantain herb, South African leaf, radix bupleuri and schizonepeta spike. The invention relates to the technical field of traditional Chinese medicines, particularly provides a traditional Chinese medicine composition capable of effectively treating various compound symptoms such as severe cough, hemoptysis, headache, dizziness and low fever caused by viral respiratory tract infection at the same time, and solves the problem of inaccurate conversion of medication dosage for children at the same time.

Disclosed herein are methods for the treatment of cancer and inflammatory-based diseases and disorders, such as coronavirus colds and as a therapy against COVID-19. ImmunoFolate has been shown to reduce the incidents of colds and flus. In one embodiment is a method of treating cancer comprising administration of ImmunoFolate. In another embodiment is a method of treatment inflammatory -based disease and disorders comprising administration of ImmunoFolate.

Disclosed herein are methods for the treatment of cancer and inflammatory-based diseases and disorders, such as coronavirus colds and as a therapy against COVID-19. ImmunoFolate has been shown to reduce the incidents of colds and flus. In one embodiment is a method of treating cancer comprising administration of ImmunoFolate. In another embodiment is a method of treatment inflammatory-based disease and disorders comprising administration of ImmunoFolate.

The invention belongs to the technical field of traditional Chinese medicine application, and provides a bamboo juice and radix tetrastigme composition for treating common cold and high fever in children. The composition of the bamboo juice and the radix tetrastigme provided by the invention has an obvious effect of quickly relieving the common cold and high fever in children, and provides a new medicine for treating common cold and fever in children; the pharmaceutical composition can be taken orally and is high in safety.